GW Wins Contract to Develop Antidote-Bearing Organisms to Protect Against Biological, Chemical Threats

GW researchers will use CRISPR/Cas9 technology to genetically modify commensal organisms to help neutralize threats experienced by warfighters and first responders
Press Releases

The George Washington University School of Medicine and Health Sciences researchers have been awarded a $3.6 million contract to genetically modify commensal organisms to produce antidotes for harmful biological and chemical agents, such as anthrax, Ebola, and even COVID-19.

Press Release

Latest News

Paprika Berry, Jada Convington, and Pedro Gazzinelli holding a presentation check for an award of $5,000 for their innovative project, Weigh2Dose.
Pedro Gazzinelli, Paprika Berry and Jada Covington awarded "Global Impact Award" in GW New Venture Competition
Congratulations to Paprika Berry, Pedro Gazzinelli and Jada Covington (a PhD student in the IBS program - former rotating student) from the Gazzinelli lab, for advancing to the Top 5 in the GW New Venture Competition in the Healthcare track! Their innovative project, Weigh2Dose, also earned them…
Illustration of work conducted by professors Paul J. Brindley, PhD, and Wannaporn Ittiprasert Tanno, PhD
GW Researchers Develop Model to Study Neglected Tropical Diseases
Researchers at the George Washington University (GW) School of Medicine and Health Sciences (SMHS), in collaboration with colleagues in France and Germany, have developed a model organism from a genetically modified parasitic worm to better study neglected tropical disease.
Brita Ostermeier from the Maggirwar Lab awarded "Young Investigator Award for the Most Outstanding Oral Presentation" at the Society on Neuroimmune Pharmacology Conference
Brita Ostermeier from the Maggirwar Lab awarded "Young Investigator Award for the Most Outstanding Oral Presentation" at the Society on Neuroimmune Pharmacology Conference